Meeting
2015 Gastrointestinal Cancers Symposium
Recurrence-free survival results from a pilot study of adjuvant gefitinib in resected hepatocellular carcinoma (HCC).
Authors
Akhil Chopra
Johns Hopkins Singapore International Medical Centre, Singapore, Singapore
Akhil Chopra , Gilberto Lopes , Lavina D. Bharwani , Chung Yip Chan , Alexander Chung , Peng Chung Cheow , Choon Kiat Ho , Kui Hin Liau , Winston Woon , Jee Keem Low , Alex Yuang-Chi Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT00282100
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 404)
DOI
10.1200/jco.2015.33.3_suppl.404
Abstract #
404
Poster Bd #
D23
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Identification and in silico structural insights of rare recurrent EGFR mutations as resistance mechanisms to osimertinib in EGFR-mutated lung cancer.
First Author: N/a Zhoutong
Poster
2018 Gastrointestinal Cancers Symposium
Clinical significance of high expression of a specific solute carrier transporter in HCC.
First Author: Patricia Gifu
Poster
2017 ASCO Annual Meeting
Panitumumab in platinum-sensitive epithelial ovarian cancer patients with KRAS wild-type: The PROVE-study, a phase II randomized multicenter study of the North-Eastern German Society of Gynaecologic Oncology.
First Author: Radoslav Chekerov
Poster
2016 ASCO Annual Meeting
Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck.
First Author: Aarti K. Bhatia